MarketAxess (MKTX)
(Delayed Data from NSDQ)
$287.60 USD
+0.20 (0.07%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $287.26 -0.34 (-0.12%) 4:30 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$287.60 USD
+0.20 (0.07%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $287.26 -0.34 (-0.12%) 4:30 PM ET
2-Buy of 5 2
F Value B Growth D Momentum D VGM
Zacks News
MarketAxess Stock Before Q3 Earnings: Buy Now or Wait for Results?
by Zacks Equity Research
MKTX's third-quarter earnings are likely to have benefited from growing trading volumes and increased utilization of its product suite.
Curious about MarketAxess (MKTX) Q3 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for MarketAxess (MKTX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Will Intercontinental Exchange Pull Off a Surprise in Q3 Earnings?
by Zacks Equity Research
ICE's Q3 results are likely to reflect pricing and reference data business growth, strength in index business, higher commodities volume and financials volume.
Is a Beat in the Cards for Cboe Global This Earnings Season?
by Zacks Equity Research
CBOE's Q3 results are likely to reflect solid proprietary products, growth in recurring non-transaction revenues, higher volumes and higher physical port fees.
Nasdaq (NDAQ) Tops Q3 Earnings Estimates
by Zacks Equity Research
Nasdaq (NDAQ) delivered earnings and revenue surprises of 7.25% and 1.80%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.13% and 0.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Strong Commercial Lines Aid Hartford Financial's Q3 Earnings?
by Zacks Equity Research
Robust Commercial Lines, Personal Lines unit, coupled with rate hikes and strong investment income, are expected to have contributed to HIG's earnings beat.
Can CME Group Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Can MarketAxess (MKTX) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
MarketAxess (MKTX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MarketAxess (MKTX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
MarketAxess (MKTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globe Life Banks on Solid Segmental Growth Amid Cost Woes
by Zacks Equity Research
GL gains from premium growth, higher invested assets and a strong liquidity position. Escalating expenses and high leverage are major concerns.
Principal Financial to Gain From Solid Segmental Performance
by Zacks Equity Research
PFG gains from new business opportunities, favorable return on capital, financial stability and effective capital deployment.
MarketAxess Reports Record Credit Trading Volumes for Q3
by Zacks Equity Research
MKTX reports strong growth in U.S. high-grade, emerging markets and eurobonds ADV in the third quarter.
ICE Trading at Premium to Industry at 24.93X: What Should You Do?
by Tanuka De
Investors who already hold Intercontinental Exchange stock should retain it and new investors can wait for a better entry point given its growth prospects.
MarketAxess (MKTX) Moves 7.5% Higher: Will This Strength Last?
by Zacks Equity Research
MarketAxess (MKTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Nasdaq Trading Near 52-Week High: How Should You Play the Stock?
by Zacks Equity Research
NDAQ is poised to gain from impressive organic growth, strategic buyouts to capitalize on growing market opportunities and effective capital deployment.
MarketAxess Rises 17% in Past Six Months: More Growth on the Horizon?
by Zacks Equity Research
MKTX remains well-poised for growth on commission growth, driven by increased trading volumes and strategic partnerships like its expanded collaboration with BlackRock.
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global and MarketAxess have been highlighted in this Industry Outlook article.
5 Securities and Exchanges Stocks to Watch Amid Market Volatility
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
MarketAxess Expands Partnership With BlackRock, Enhances Offerings
by Zacks Equity Research
MKTX expands its partnership with BlackRock to improve the trading experience for clients.
MarketAxess (MKTX) Surges 6.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
MarketAxess (MKTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MarketAxess (MKTX) Up 5.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MarketAxess (MKTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Investors Should Hold MarketAxess (MKTX) Stock
by Zacks Equity Research
MarketAxess (MKTX) remains well-poised for growth on the back of expanding commissions, product launches and sound cash reserves.
5 Stocks to Watch on Recent Dividend Hikes Amid Recession Fears
by Santanu Roy
Investors may keep a tab on stocks like BMA, NOG, FOXA, SHIP and MKTX, which have lately hiked their dividend payments.
MarketAxess (MKTX) Q2 Earnings Beat on Higher Commissions
by Zacks Equity Research
MarketAxess' (MKTX) second-quarter earnings benefit from improved commissions. However, rising expenses and lesser trading activity of U.S. high-yield partially offset the positives.